In PHARMA, I wrote:

"Under Justice Department regulations, (U.S. Attorney) Brownlee’s superiors in Washington had to sign off on his case. He forwarded it to headquarters in 2006. The Criminal Division career prosecutors who reviewed it recommended the most serious charges. One reason for their confidence was a confidential Department of Justice memorandum prepared by Brownlee’s team that determined that senior Purdue executives were aware of OxyContin’s abuse problems within months of its 1996 ...